Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis

The secondary objectives of this are:

• to study plasma NGAL levels on admission to the emergency ward as a marker of morbidity and mortality by considering the following factors: duration of hospitalization, need for extracorporeal blood purification, ICU admission, death.
• to study the delay between the onset of the proposed cause of rhabdomyolysis and treatment initiation
• to study the delay between treatment initiation and the occurrence of ARF.

Inclusion criteria

• The patient must have given his/her informed and signed consent
• The patient must be insured or beneficiary of a health insurance plan
• Patient hospitalized with Creatine Phospho-Kinase > 1000 UI/l

Exclusion criteria

• The patient is participating in another study
• The patient is in an exclusion period determined by a previous study
• The patient is under judicial protection, under tutorship or curatorship
• The patient refuses to sign the consent
• It is impossible to correctly inform the patient
• The patient is pregnant, parturient, or breastfeeding
• Chronic renal insufficiency with dialysis
• The patient has an acute coronary syndrome
• Nephrotoxic medications within 72 hours prior to admission
• Need for a procedure involving the injection of iodine
• Patient in shock
• Occurrence of acute renal failure can be explained by a cause other than rhabdomyolysis.